Infinium Global Research Wearable Injectors Market | Page 2

Wearable Injectors Market: Trends and Forecasts up to 2024
The Infinium Global Research analyzes the report of Wearable Injectors Market
over the period of 2018 to 2024. This report also provides detailed qualitative and
quantitative analyses of the market dynamics, market size and future trends in
Global Wearable Injectors Market. It will help a lot of decision makers to develop
strategies and find new opportunities in the Global markets of Wearable Injectors.
The report covers market changing aspects including drivers, restraints,
opportunities, and trends expected to encouragement the expansion of the
Wearable Injectors Market during the said period. The report also provides market
attractiveness analysis, by geography, and market share analysis, by key players
respectively. Some of the prominent participants in the Global Wearable Injectors
Market are SteadyMed Therapeutics, Inc, Sensile Medical AG, Debiotech S.A.,
CeQur SA., West Pharmaceutical Services, Inc., Ypsomed AG, Insulet Corporation,
Tandem Diabetes Care, Inc. and F. Hoffmann-La Roche Ltd. According to report the
global wearable injectors market is projected to grow at a CAGR of 13.4% over the
forecast period of 2018-2024.
For More Details Get Free Few Sample Pages of this Premium Report: -
https://www.infiniumglobalresearch.com/reports/sample-request/1778
Wearable Injectors or patch pumps or patch injector are drug delivery devices,
designed specifically for patients, for self-administration of large volume drugs. It
used for the subcutaneous injection of insulin and other drugs delivery which
infuses, 2-10ml of the drug, within 2-15 minutes. A large number of new biologic
require high doses and viscous formulation that cannot be injected by using a
syringe or another legacy system hence they delivered intravenously or novel drug
delivery technology that is eco-friendly, Safe and cost-effective. Improved quality of
life of patients’ with self-administered wearable injector used in the home
environment. Wearable injector technology platform enables cost-effective, easy,
reliable, comfortable and flexible drug delivery.
Wearable injectors are convenient and cost-effective self-administration platform
for large and viscous doses. High prevalence of chronic diseases, cardiovascular
disease, blood disorders and infectious disease requires large and viscous doses
which in turn, is driving the demand for the wearable injector market. Moreover,
growing awareness related to the need stick injuries and rising in the population
are also the factors, augmenting the market growth of the wearable injectors
market. In addition, rising demand for warble injectors is the largest driver for the
pharmaceutical and biotechnology market.
2
© Infinium Global Research